Boundless Bio CEO Zachary Hornby sat down with Proactive’s Christine Corrado at BIO CEO in New York. is a biotechnology company focused on interrogating a novel area of cancer biology, extrachromosomal DNA to deliver transformative therapies to patients with previously intractable cancers.
Boundless Bio takes big steps forward filling out their staff
